You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 15, 2025

List of Excipients in API TADALAFIL


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing TADALAFIL

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Eli Lilly and Company CIALIS tadalafil 0002-4465 CELLULOSE, MICROCRYSTALLINE
Eli Lilly and Company CIALIS tadalafil 0002-4465 CROSCARMELLOSE SODIUM
Eli Lilly and Company CIALIS tadalafil 0002-4465 FERRIC OXIDE RED
Eli Lilly and Company CIALIS tadalafil 0002-4465 FERRIC OXIDE YELLOW
Eli Lilly and Company CIALIS tadalafil 0002-4465 HYDROXYPROPYL CELLULOSE
Eli Lilly and Company CIALIS tadalafil 0002-4465 HYPROMELLOSE
Eli Lilly and Company CIALIS tadalafil 0002-4465 LACTOSE MONOHYDRATE
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing TADALAFIL

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc tadalafil 0093-3016 CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals USA Inc tadalafil 0093-3016 CROSCARMELLOSE SODIUM
Teva Pharmaceuticals USA Inc tadalafil 0093-3016 FERRIC OXIDE YELLOW
Teva Pharmaceuticals USA Inc tadalafil 0093-3016 LACTOSE MONOHYDRATE
Teva Pharmaceuticals USA Inc tadalafil 0093-3016 POLYETHYLENE GLYCOL 3350
Teva Pharmaceuticals USA Inc tadalafil 0093-3016 POLYETHYLENE GLYCOL 4000
Teva Pharmaceuticals USA Inc tadalafil 0093-3016 POLYVINYL ALCOHOL
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for TADALAFIL

Excipient focus: ACACIA

Excipient focus: ALUMINUM OXIDE

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: CARMINIC ACID

Excipient focus: CELLULOSE, MICROCRYSTALLINE

TADALAFIL drug variants containing CELLULOSE, MICROCRYSTALLINE

Company Ingredient NDC
Eli Lilly and Company tadalafil 0002-4465
Teva Pharmaceuticals USA Inc tadalafil 0093-3016
Teva Pharmaceuticals USA Inc tadalafil 0093-3334
Mylan Pharmaceuticals Inc tadalafil 0378-6970
Mylan Pharmaceuticals Inc tadalafil 0378-6971
Mylan Pharmaceuticals Inc tadalafil 0378-6976
Torrent Pharmaceuticals Limited tadalafil 13668-565
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: CI 77891

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: COPOVIDONE

Excipient focus: COPOVIDONE K25-31

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: DIMETHICONE

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE

TADALAFIL drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE

Company Ingredient NDC
Eli Lilly and Company tadalafil 0002-4465
Teva Pharmaceuticals USA Inc tadalafil 0093-3016
Teva Pharmaceuticals USA Inc tadalafil 0093-3334
Mylan Pharmaceuticals Inc tadalafil 0378-6970
Mylan Pharmaceuticals Inc tadalafil 0378-6971
Mylan Pharmaceuticals Inc tadalafil 0378-6976
Teva Pharmaceuticals Inc tadalafil 0480-2308
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C YELLOW NO. 5

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: FRUCTOSE

Excipient focus: GLYCERIN

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

TADALAFIL drug variants not containing HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED

Company Ingredient NDC
Eli Lilly and Company tadalafil 0002-4465
Teva Pharmaceuticals USA Inc tadalafil 0093-3016
Teva Pharmaceuticals USA Inc tadalafil 0093-3334
Mylan Pharmaceuticals Inc tadalafil 0378-6970
Mylan Pharmaceuticals Inc tadalafil 0378-6971
Mylan Pharmaceuticals Inc tadalafil 0378-6976
Teva Pharmaceuticals Inc tadalafil 0480-2308
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: HYDROXYPROPYL METHYLCELLULOSE

TADALAFIL drug variants not containing HYDROXYPROPYL METHYLCELLULOSE

Company Ingredient NDC
Eli Lilly and Company tadalafil 0002-4465
Teva Pharmaceuticals USA Inc tadalafil 0093-3016
Teva Pharmaceuticals USA Inc tadalafil 0093-3334
Mylan Pharmaceuticals Inc tadalafil 0378-6970
Mylan Pharmaceuticals Inc tadalafil 0378-6971
Mylan Pharmaceuticals Inc tadalafil 0378-6976
Teva Pharmaceuticals Inc tadalafil 0480-2308
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

TADALAFIL drug variants containing HYPROMELLOSES

Company Ingredient NDC
Unichem Pharmaceuticals (USA) Inc tadalafil 29300-286
Macleods Pharmaceuticals Limited tadalafil 33342-265
Macleods Pharmaceuticals Limited tadalafil 33342-278
Northwind Pharmaceuticals LLC tadalafil 51655-063
Physicians Total Care Inc tadalafil 54868-5956
Dispensing Solutions Inc tadalafil 66336-566
Qilu Pharmaceutical Co Ltd tadalafil 67184-0523
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

TADALAFIL drug variants not containing LOW-SUBSTITUTED HYDROXYPROPYL CELLULOSE

Company Ingredient NDC
Eli Lilly and Company tadalafil 0002-4465
Teva Pharmaceuticals USA Inc tadalafil 0093-3016
Teva Pharmaceuticals USA Inc tadalafil 0093-3334
Mylan Pharmaceuticals Inc tadalafil 0378-6970
Mylan Pharmaceuticals Inc tadalafil 0378-6971
Mylan Pharmaceuticals Inc tadalafil 0378-6976
Teva Pharmaceuticals Inc tadalafil 0480-2308
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: MAGNESIUM

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MANNITOL

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

TADALAFIL drug variants not containing MICROCRYSTALLINE CELLULOSE 102

Company Ingredient NDC
Eli Lilly and Company tadalafil 0002-4465
Teva Pharmaceuticals USA Inc tadalafil 0093-3016
Teva Pharmaceuticals USA Inc tadalafil 0093-3334
Mylan Pharmaceuticals Inc tadalafil 0378-6970
Mylan Pharmaceuticals Inc tadalafil 0378-6971
Mylan Pharmaceuticals Inc tadalafil 0378-6976
Teva Pharmaceuticals Inc tadalafil 0480-2308
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLOXAMER 188

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 4000

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYOXYL 40 HYDROGENATED CASTOR OIL

TADALAFIL drug variants containing POLYOXYL 40 HYDROGENATED CASTOR OIL

Company Ingredient NDC
Camber Pharmaceuticals Inc tadalafil 31722-643
Camber Pharmaceuticals Inc tadalafil 31722-647
Burel Pharmaceuticals LLC tadalafil 35573-409
PD-Rx Pharmaceuticals Inc tadalafil 43063-969
A-S Medication Solutions tadalafil 50090-4247
A-S Medication Solutions tadalafil 50090-4276
A-S Medication Solutions tadalafil 50090-4660
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

TADALAFIL drug variants not containing POLYOXYL 40 HYDROGENATED CASTOR OIL

Company Ingredient NDC
Eli Lilly and Company tadalafil 0002-4465
Teva Pharmaceuticals USA Inc tadalafil 0093-3016
Teva Pharmaceuticals USA Inc tadalafil 0093-3334
Mylan Pharmaceuticals Inc tadalafil 0378-6970
Mylan Pharmaceuticals Inc tadalafil 0378-6971
Mylan Pharmaceuticals Inc tadalafil 0378-6976
Teva Pharmaceuticals Inc tadalafil 0480-2308
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: POVIDONE

Excipient focus: POVIDONE K25

Excipient focus: POVIDONE K30

Excipient focus: SILICA

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BENZOATE

Excipient focus: SODIUM CITRATE

Excipient focus: SODIUM LAURETH SULFATE

Excipient focus: SODIUM LAURYL FUMARATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A CORN

TADALAFIL drug variants not containing SODIUM STARCH GLYCOLATE TYPE A CORN

Company Ingredient NDC
Eli Lilly and Company tadalafil 0002-4465
Teva Pharmaceuticals USA Inc tadalafil 0093-3016
Teva Pharmaceuticals USA Inc tadalafil 0093-3334
Mylan Pharmaceuticals Inc tadalafil 0378-6970
Mylan Pharmaceuticals Inc tadalafil 0378-6971
Mylan Pharmaceuticals Inc tadalafil 0378-6976
Teva Pharmaceuticals Inc tadalafil 0480-2308
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

TADALAFIL drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO

Company Ingredient NDC
Eli Lilly and Company tadalafil 0002-4465
Mylan Pharmaceuticals Inc tadalafil 0378-6970
Mylan Pharmaceuticals Inc tadalafil 0378-6971
Mylan Pharmaceuticals Inc tadalafil 0378-6976
Teva Pharmaceuticals Inc tadalafil 0480-2308
Teva Pharmaceuticals Inc tadalafil 0480-2309
Teva Pharmaceuticals Inc tadalafil 0480-9277
>Company >Ingredient >NDC

Subscribe to access the full database, or Get Started Free

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: SORBITAN MONOSTEARATE

Excipient focus: SOYBEAN LECITHIN

Excipient focus: STARCH, CORN

Excipient focus: SUCRALOSE

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: TRICETIN

Excipient focus: TRISODIUM CITRATE DIHYDRATE

Excipient focus: WATER

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links